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The inﬂuenza A(H1N1)pdm09 virus has circulated worldwide and continued to cause complicated
infections and deaths. Reports have identiﬁed an increased prevalence of the hemagglutinin receptor
binding domain D222G mutation in viruses isolated from individuals who have suffered such severe
infections, but this association is still unclear. Virus isolated from a nasopharyngeal wash of a severely
ill immunocompromised patient at the time of diagnosis contained the D222, but isolates collected
later in his course from a bronchoalveolar lavage contained primarily the G222 mutation and was
mixed with a minor population of D222. These clinical isolates were compared to a G222 plaque
puriﬁed virus in the ferret model. The G222 predominant clinical isolate was the most pathogenic in
ferrets and developed the most diversity at the 222 amino acid position during infection, suggesting
that increased diversity and not a speciﬁc polymorphism at HA 222 may be important in predicting
pathogenic potential.
Published by Elsevier Inc.Introduction
The 2009 pandemic H1N1 inﬂuenza A virus [A(H1N1)pdm09]
emerged in March 2009 and caused signiﬁcant morbidity and
mortality worldwide (Bautista et al., 2010). It has continued to
circulate post-pandemically in an annual, seasonal pattern along
with H3N2 and inﬂuenza B viruses. Early during the 2009
pandemic, amino acid polymorphisms in the receptor binding
domain of the hemagglutinin gene (HA) were identiﬁed
(Chutinimitkul et al., 2010; Kilander et al., 2010; WHO, 2010),
and an association was made with severe disease or fatal out-
comes (Kilander et al., 2010). Speciﬁcally, reports have documen-
ted an association with severe inﬂuenza and isolation of
pandemic viruses with position 222 mutations from the consen-
sus Aspartic acid (D) to either Glycine (G) or Asparagine (N)
(Baldanti et al., 2010; Baumeister et al., 2010; Drews et al., 2010;
Ertek et al., 2010; Ikonen et al., 2010; L’Vov et al., 2010; Potdar
et al., 2010; Puzelli et al., 2010; Wang et al., 2011). Another
variant codon at position 222, Glutamic acid (E), has beenInc.
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moli).observed but has not been associated with severe disease
(Puzelli et al., 2010). These observations suggested that mutations
in this region, particularly the G222 mutation, may be important
virological virulence factors associated with severe outcomes in
A(H1N1)pdm09 infection. In vivo studies suggest these severe
outcomes may be due to the G222 mutation inﬂuencing receptor
binding speciﬁcity leading to a more severe lower respiratory
tract infection (Liu et al., 2010; Watanabe et al., 2011). Studies
comparing viruses isolated from nasal swabs with matched
isolates from bronchoalveolar lavage (BAL) specimens have
shown that 222G variants have been isolated in higher percen-
tages from the BAL samples (Baldanti et al., 2010; Chutinimitkul
et al., 2010). Matched nasopharyngeal wash and BAL isolates are
only available from small numbers of patients, predominantly
severely ill ones, so that comparable studies with viruses isolated
from patients with mild inﬂuenza have not been performed.
Interestingly these HA D222G or D222N mutations have also
been identiﬁed in primary sequence analysis of cases of pandemic
inﬂuenza from 1918 (Reid et al., 2003; Sheng et al., 2011) with
222G identiﬁed in 5/16 (37.5%) autopsy cases; and a mixture of
222G/222N in a single case. However, case histories, histopatho-
logic changes, and immunohistochemical analyses for viral anti-
gen distribution showed no differences between the 1918 cases
with D222 versus G222.
M.J. Memoli et al. / Virology 428 (2012) 21–2922Experimental animal studies with G222 viruses derived by
mutagenesis and reverse genetics (Belser et al., 2011) or serial
mouse passage (Zheng et al., 2010) have reported enhanced
pathogenesis in mice following intranasal inoculation as com-
pared to D222 viruses, but a comparable study in ferrets, showed
no signiﬁcant differences in either pathogenesis or transmissi-
bility (Belser et al., 2011). A study in macaques which matched
pairs of isogenic A(H1N1)pdm09 viruses, expressing either D222
or G222, generated conﬂicting data, with the G222 virus of one
matched pair showing enhanced pathogenicity from one set of
viruses but not with the other (Watanabe et al., 2011).
Thus, the signiﬁcance of these HA receptor binding domain
polymorphisms is still unclear, and the effects on disease and
mechanisms by which they arise have not been fully elucidated. In
this report, serially isolated viruses from a previously described
immunocompromised patient (Memoli et al., 2010b) with a severe
A(H1N1)pdm09 infection were analyzed. The initial isolate, col-
lected from a nasopharyngeal (NP) wash at the time of diagnosis,
was noted to encode a D222 in the HA protein. An isolate collected
from the lungs by bronchoalveolar lavage (BAL) after the patient
developed severe disease on day 24 encoded a G222 in the HA
protein, while virus collected from an NP wash at the same time
still demonstrated D222. All subsequent viruses isolated from
nasal samples throughout this patient’s course of infection were
shown to express HA with D222. Given this observation, we
performed analyses of quasispecies of the viruses isolated from
this patient. Using these data and the viruses isolated, we sought
to determine the signiﬁcance of the changes at position 222 in
these isolates and their quasispecies through evaluation of clinical
disease, pathogenesis and, transmissibility in the ferret model.Results
Initial viral analysis
The initial sequencing of the initial NP isolate has been previously
published and submitted to Genbank (A/Bethesda/NIH106-D0/
2009(H1N1), accession numbers: HQ263268-HQ263274, GU571154)
(Memoli et al., 2010a, 2010b). The BAL isolate gene sequences except
for the HA and NA were identical to those of the NP wash isolate. The
NA gene contained the H275Y mutation, identical to the NA from the
resistant virus previously isolated from this patient (accession
GU57115) (Memoli et al., 2010b), and the HA gene was found to
have a single difference with the NP wash HA sequence at position
222 with a change from D to G.
By performing colony PCR, the initial clinical isolate collected
by NP wash was determined to contain a D at position 222 of the
HA1 domain with 100% of clones sequenced demonstrating that
genotype (Table 1). The isolate collected by BAL during the period
of the patient’s most severe illness was determined to be a mixed
isolate with quasispecies containing primarily G222 (92%), but
a small but signiﬁcant (8%) percentage of D222 (Table 1). The
plaque-puriﬁed virus from the BAL specimen was conﬁrmed to
contain a pure population of virus with 100% of clones containingTable 1
Amino acida 222 variation of viruses used for inoculation.
NP clinical
isolate (%)
BAL clinical
isolate (%)
Plaque puriﬁed
virus (%)
D 100 8 0
G 0 92 100
N 0 0 0
S 0 0 0
a Aspartic acid (D), Glycine (G), Asparagine (N), Serine (S).G222 (Table 1). No other mutations in the HA gene were noted in
the colonies analyzed.
In vivo evaluation in ferrets
Ferrets inoculated with the NP wash isolate (with D222)
developed a moderate course of illness with peak weight loss of
12% on day 6 (Fig. 1A) and clinical symptoms on day 5 post-
inoculation with a mean score 2.25 (Fig. 1C), consistent with
previous studies (Memoli et al., 2010a). Those animals inoculated
with the BAL isolate (D222/G222 mixture) also developed a
statistically similar moderate course of illness with a mean peak
clinical score of 2.5 (p¼0.537) and weight loss of 11% (p¼0.792)
(Fig. 1A, C). This course of illness was signiﬁcantly different from
that of the animals inoculated with the plaque puriﬁed 222G
containing isolate. In this group, the animals demonstrated
minimal illness with a slower progression and signiﬁcantly lower
mean peak clinical score of 1.25 than the other two groups
(p¼0.03, 0.017 respectively) (Fig. 1C). Weight loss was also
signiﬁcantly less throughout the fourteen days, with mean peak
weight loss of 2.36% (p¼0.022, 0.031 respectively) and faster
recovery (Fig. 1A).
Differences became even more apparent in those animals that
were exposed to those that were inoculated. Those animals
exposed to either the NP isolate or the BAL isolate both demon-
strated moderate clinical illness with a mean peak clinical score of
2–3 by day 3 post-exposure, but those animals exposed to the NP
isolate recovered more quickly. Ferrets exposed to the BAL isolate
were still demonstrating signiﬁcant illness by day 5 post-expo-
sure (day 7 post-inoculation) as compared to those exposed to the
NP isolate; with one animal progressing to death (Fig. 1D). A more
signiﬁcant weight loss was observed in those animals exposed to
the BAL isolate, with a mean peak weight loss of 18.62%, as
compared to 4.93% in the NP isolate group (p¼0.004) (Fig. 1B). In
stark contrast to those exposed by transmission to the clinical
nasopharyngeal wash and BAL isolates, animals exposed to the
plaque-puriﬁed G222 virus demonstrated minimal clinical symp-
toms, with some animals demonstrating no symptoms (Fig. 1D).
Weight loss was also minimal with most animals gaining weight
throughout their course (Fig. 1B).
Viral shedding and lung titers
Despite the differences in clinical disease, regardless of virus
exposure all animals were found to shed virus nasally and
transmission was noted in 100% of the animals exposed to
inoculated animals. All animals shed virus for at least 5 days,
and no signiﬁcant difference was noted in the amount of viral
shedding (Fig. 2). It was noted that those animals inoculated
or exposed by transmission to the plaque puriﬁed G222 virus
reached peak shedding one day later than those exposed to the
clinical isolates. In the animals sacriﬁced on day 5, no signiﬁcant
difference in lung titer was noted between the groups, with virus
recovered from the homogenized lungs of all animals at titers of
105–107 pfu/g.
Pathology
All animals euthanized on day 5 post-exposure demonstrated
a range of histopathology equivalent to that described in detail
previously (Memoli et al., 2010a). In brief, mild multifocal disease of
the nasopharynx, larynx and trachea was observed with laryngitis,
tracheitis, and bronchial gland sialadenitis. Within the lungs there
was a mild to moderate bronchitis, moderate to severe pan-bronch-
iolitis, variable amounts of alveolitis and interstitial pneumonia and
in the most severe cases patches of acute pneumonia as well as
Fig. 1. Mean weight loss and clinical scores in infected ferrets. All ferrets demonstrated evidence of clinical disease by clinical score in both the inoculated (C) and
transmission groups (D), with the least disease seen in those animals infected with the 222G Plaque Puriﬁed Virus. This was consistent with weight loss observed in the
inoculated (A) and transmission (B) groups. Error bars represent SEM.
M.J. Memoli et al. / Virology 428 (2012) 21–29 23congestion, edema and rarely hemorrhage. Inﬂammation was mixed
lymphohistiocytic and neutrophilic (Fig. 3). In the lungs, the bronchial
gland sialadenitis was generally more severe than its neighboring
bronchitis. Immunohistochemistry revealed multifocal viral antigenlabeling in the bronchial epithelium, bronchioles, and alveolar epithe-
lial cells and alveolar macrophages in the areas of focal alveolitis
(Fig. 3). At the day 12 post-inoculation time point there were rare foci
of inﬂammation within the upper respiratory tract, and occasional
Fig. 2. Mean quantity of viral RNA detected by qPCR in the nasal washes of ferrets after inoculation (A) and by transmission (B). All animals shed virus during the course of
infection to similar titers regardless of virus exposure. 100% transmission was noted as well. Error bars represent SEM.
M.J. Memoli et al. / Virology 428 (2012) 21–2924foci of resolving bronchointerstitial pneumonias with evidence of
repair, as previously described (Memoli et al., 2010a).
When comparing groups of animals, the day 5 post-inocula-
tion pathology coincided with the clinical disease observed. Those
animals inoculated with the BAL isolate demonstrated slightly
more severe pathology than those inoculated or exposed by
transmission to the NP isolate, but were very similar (Fig. 3).
All of the animals inoculated or exposed by transmission with
the BAL or NP isolate demonstrated more diffuse and extensivepathology than those infected with the plaque puriﬁed G222
virus. In both the inoculation and transmission groups, these
animals demonstrated limited pathology (Fig. 3).
One ferret exposed to a ferret inoculated with the BAL isolate
died on day 9 post-exposure. Histopathologic analysis revealed a
bronchopneumonia with Gram-negative bacilli (data not shown).
Gram stains were additionally done on several other acute time-
point ferret tissues representing the full range of pathology scores
and all were negative.
Fig. 3. H&Es and inﬂuenza antigen IHCs of day 5 post-inoculation ferret lung. (A) H&E of NP inoculated ferret, (B) IHC of same NP inoculated ferret including inset of
inﬂuenza antigen labeling of uninfected ferret tissue, (C) H&E of BAL inoculated ferret, (D) IHC of same BAL inoculated ferret, (E) H&E of plaque puriﬁed G222 inoculated
ferret, (F) IHC of same plaque puriﬁed G222 ferret. ‘‘a’’ designates an alveolar lumen and ‘‘b’’ designates a bronchiolar lumen. Original magniﬁcation 80 .
M.J. Memoli et al. / Virology 428 (2012) 21–29 25Sequencing and quasispecies of ferret isolates
More HA genome diversity was noted in those animals
exposed by transmission (Table 3), and the BAL isolate developed
the most diversity during infections of the animals. This diversity
included the identiﬁcation of an Asparagine (N) at site 222 in
virus isolated from the nasal turbinate and a change from G222 to
D222 predominance in the lung after transmission (Tables 2 and 3).
The NP wash isolate also developed signiﬁcant diversity at posi-
tion 222 during infection of the animals, but still maintained a D
predominance throughout both the upper and lower airways
(Tables 2 and 3). The plaque-puriﬁed virus developed the leastdiversity during infection, with 98–100% of quasispecies main-
taining the 222G in both upper and lower airway (Tables 2 and 3).
Phylogenetic analysis
Intrahost codon usage at site 222 revealed a strong bias
towards a particular codon for the different variants isolated from
the ferrets. The G222 variants showed a preference for the glycine
codon, GGT. The aspartic acid variants, D222, showed a speciﬁcity
for GAT. A population level analysis of codon usage at amino acid
site 222 of HA sequences of 2009 pandemic H1N1 revealed an
identical pattern for the G222 and D222 variants. Phylogenetic
M.J. Memoli et al. / Virology 428 (2012) 21–2926analysis showed the G222 variants as either sporadic, one-off
mutations with no further transmission over time, or rare, small
monophyletic clades with limited transmission and very little
persistence over time (Supplemental Fig. S1). A monophyletic
clade containing mostly E222 variants within the HA phyloge-
netic tree shows a pronounced pattern of persistence and trans-
mission across countries. A similar pattern was found with these
E222 variants in the NA phylogenetic tree.Discussion
The isolation of viruses from this patient containing different
HA receptor binding site polymorphisms at position 222 demon-
strates that mutations in the HA can occur rapidly in a human
host increasing quasispecies diversity with different predomi-
nance in the upper and lower respiratory tract. Rapid increase in
quasispecies diversity was also seen in the ferret model when
clinical isolates were used to inoculate the animals, and a great
increase in quasispecies was observed especially after transmis-
sion in both the upper and lower airways. In contrast, much less
diversity developed after infection with the plaque-puriﬁed virus.
This was likely due to a lack of signiﬁcant quasispecies present
and/or selective pressures minimizing the ability of the pure
G222 population to change. The clinical NP wash isolate that was
identiﬁed as only containing D222 did develop diversity at this
site rapidly, but it is possible that there were pre-existing
quasispecies present in this clinical isolate below the limits of
detection in this study. This highlights the complex nature of
development of these polymorphisms and that multiple host and
virological factors are likely involved in their development.
The presence of the H275Y mutation in the neuraminidase (NA)
gene of the BAL and plaque puriﬁed sample did not seem to have
any effect on viral ﬁtness as the BAL isolate, NP isolate, and plaque-
puriﬁed virus all grew well in culture and grew to similar titers
from the lungs of the ferrets (Fig. 4). In a previously published studyTable 2
Amino acida 222 variation of viruses isolated from inoculated ferrets.
NP clinical isolate
inoculated
BAL clinical isolate
inoculated
Plaque puriﬁed virus
inoculated
Nasal
turbinate (%)
Lung
(%)
Nasal
turbinate (%)
Lung
(%)
Nasal
turbinate (%)
Lung
(%)
D 100 81 7 13 2 0
G 0 0 93 87 98 100
N 0 17 0 0 0 0
S 0 2 0 0 0 0
a Aspartic acid (D), Glycine (G), Asparagine (N), Serine (S).
Table 3
Amino acida 222 variation of viruses isolated from transmission ferrets.
NP clinical isolate
transmission
BAL clinical isolate
Transmission
Plaque puriﬁed virus
Transmission
Nasal turbinate
(%)
Lung
(%)
Nasal turbinate
(%)
Lung
(%)
Nasal turbinate
(%)
Lung
(%)
D 52 55 41 62 2 0
G 48 45 46 38 98 100
N 0 0 13 0 0 0
S 0 0 0 0 0 0
a Aspartic acid (D), Glycine (G), Asparagine (N), Serine (S).
Fig. 4. Viral titers in ferret lung tissues. Virus was recovered from all ferret lungs
harvested on day 5 post-inoculation or exposure (transmission group). Viral titers
were similar with no statistical difference in mean titer observed between the
groups.we demonstrated that this NP isolate, containing H at position 275,
and another NP isolate from later in this same patient’s infection
that contained the H275Y mutation maintained ﬁtness and trans-
missibility in the ferret model (Memoli et al., 2010a). These data in
conjunction with the increased presence of H275Y in seasonal
H1N1 and increasing evidence that the H275Y mutation in
A(H1N1)pdm09 does not affect viral ﬁtness, transmissibility, or
pathogenesis (Hamelin et al.; Seibert et al., 2009; van der Vries
et al., 2009); it seems likely that the presence of the H275Y
mutation did not play a role in the differences observed here.
Although in vitro studies have demonstrated that the D222G
mutation may alter receptor speciﬁcity and cell tropism allowing
binding of a broader range of a2-3-linked sialyl receptor sequences
on ciliated bronchial epithelial cells and on lung epithelia (Liu et al.,
2010; Watanabe et al., 2011), we did not observe any differences in
viral antigen distribution, viral titer, or range of histopathology in
the upper and lower airways in the ferret model. Additionally,
regardless of HA residue 222 sequence, all viruses grew well and
were fully transmissible. These data are consistent with a recent
study demonstrating similar disease in ferrets infected with a
reverse genetics derived mutant virus and a high passage vaccine
strain derived from A/CA/04/2009 (H1N1) (Belser et al., 2011).
Although the results of the above studies were similar to what
we observed, the current study has some signiﬁcant differences.
By using two very low passage clinical isolates (o3 passages) and
M.J. Memoli et al. / Virology 428 (2012) 21–29 27comparing them to a plaque-puriﬁed virus, we were able to
explore not only the role of the D222G mutation itself, but also
that of the described diversity of quasispecies at this position.
While we observed differences in quasispecies proportions
depending on location in the ferret respiratory tree, it is unclear
if this difference in proportion of a certain amino acid at position
222 in the quasispecies present in the upper or lower airways was
related to differences in viral binding or cell tropism, or rather
reﬂected stochastic processes related to which viral variant
predominated in early infection.
The other signiﬁcant ﬁnding was that the plaque-puriﬁed virus
containing the G222 caused the least severe illness in ferrets,
again suggesting that it is likely that the 222G mutation is not
a sole virulence determinant of severe disease as supported by
the nonhuman primate infections described by Watanabe et al.
(2011). Interestingly, in the current study, those viral isolates
with more diversity at HA position 222 were the most pathogenic,
causing the most clinical disease, weight loss, and histopathology
as demonstrated by those animals infected by transmission with
the BAL isolate. Those animals developed the most severe clinical
course, and the viruses isolated from those animals were the most
diverse at position 222, particularly in virus isolated from the
lungs. Although those animals infected by exposure to the NP
isolate also developed considerable diversity at position 222, they
developed slightly less overall disease. This difference may have
been due to the fact that the virus causing the infection did not
contain any detectable G222 variants; suggesting that the G222
mutation may play a role in enhancing pathogenesis as part of a
diverse population.
The least diverse viruses were isolated from the animals
infected with the plaque-puriﬁed G222 isogenic clone, and these
animals demonstrated the least clinical disease and pathology
compared to the other 2 diverse infections. This difference in
pathogenicity may signify that HA receptor-binding region diver-
sity may allow virus to bind to more diverse cell types in the
initial infection, thus spreading more easily throughout the upper
and lower airways. This is similar to quasispecies diversity
determined neurotrophism and pathogenesis of polioviruses as
described by Vignuzzi et al., suggesting that diverse quasispecies
populations are the unit of selection, rather than individual
variants (Vignuzzi et al., 2006). Thus, diversity at this HA
receptor-binding site, rather than speciﬁc polymorphisms them-
selves, may be a better determinant of disease progression than a
speciﬁc amino acid change.
Although diverse 222 variants are generated at the intrahost
level and show a speciﬁcity for codon usage bias, phylogenetic
analysis of 2009–2011 gene sequence data revealed that G222
variants are a result of sporadic mutations that occur with no
forward persistence and very little transmission over time. In
contrast, E222 forms a pronounced, monophyletic clade over
time. These data suggest that variation at the amino acid site
222 is likely driven by intrahost adaptation, and that the popula-
tion snap-shot of these variants in the context of phylogenetics is
likely not indicative of pathogenic or circulating variants.Conclusions
Mutations in the HA1 receptor binding domain at position 222
of A(H1N1)pdm09 can develop rapidly as is evident in both
human cases and in the ferret model. Mutations such as the
D222G mutation likely do not mediate severe disease alone, but
may play a role in enhancing pathogenesis as a signiﬁcant part of
a diverse population of quasispecies. Increased diversity of a viral
isolate at position 222 seems more important in predicting
increased pathogenesis rather than the presence or absence ofany speciﬁc polymorphism. Although the role of these poly-
morphisms in disease progression is still unclear, their relation-
ship to pathogenesis is clearly complex, multi-factorial, and likely
context dependant. Further clinical and laboratory study will be
necessary to clearly elucidate the mechanisms by which quasispe-
cies diversity of the HA1 receptor binding region of A(H1N1)pdm09
can play a role in selection and disease progression.Materials and Methods
Viruses
After informed consent, the two clinical isolates were collected
from the patient in an IRB approved protocol (clinicaltrials.gov
identiﬁer: NCT00533182). Viruses were passaged 2 times in
MDCK cells after initial isolation. Sequencing of all 8 segments
was performed on the clinical NP isolate and the BAL isolate.
Colony PCR of the HA gene was performed on both isolates to
determine the quasispecies present. A population of virus con-
taining solely the 222G mutation was puriﬁed from the BAL
isolate using standard plaque puriﬁcation methods (Rowe and
Bau, 1965) in MDCK cells. Colony PCR of the HA gene and
sequencing was used to conﬁrm that this plaque-puriﬁed isolate
contained the 222G and was otherwise identical to the clinical
isolate.
Ferrets
Twenty four inﬂuenza A virus seronegative, 5-month-old, male
ferrets were housed in pairs in separate cages with individual
airﬂow. The ferrets were divided into six groups of four ferrets
each. Three groups were inoculated intranasally with 105 plaque
forming units (pfu) of virus, one with the original nasopharyngeal
wash clinical isolate, one with the BAL isolate, and one with the
plaque-puriﬁed 222G containing virus. After 48 h, the other three
groups were exposed to the inoculated ferrets by placing one
naive ferret in each cage with one inoculated ferret. Daily weights,
temperatures, nasopharyngeal washes and clinical scores were
performed as previously described (Memoli et al., 2009).
Two ferrets from each of the inoculated groups and transmis-
sion groups were euthanized on day 5 post-inoculation or
exposure respectively. On day 12 post-inoculation and day 12
post-exposure all remaining animals in each respective group
were euthanized. Whole lungs, trachea, and rostral nasal turbi-
nates were harvested. All animal experiments were performed
following NIH Institutional Animal Care and Use Committee
approved protocols and guidelines.
Quantiﬁcation of virus
Nasopharyngeal washes were analyzed using one step real-
time RT-PCR for the inﬂuenza A virus matrix 1 gene to quantify
viral shedding as previously described (Krafft et al., 2005).
Standard plaque assays were performed in MDCK cells (Szretter
et al., 2006) on lung tissues that were weighed and homogenized
in sterile cold Leibovitz’s medium (Gibco L-15, Invitrogen Cor-
poration Carlsbad, CA) containing 1X penicillin, streptomycin, and
amphotericin B (Gibco Anti-Anti, Invitrogen Corporation Carlsbad,
CA). All lung titers were measured as plaque forming units per
gram of tissue (pfu/g).
Sequence analysis
Viral RNA was extracted directly from the nasal turbinates and
lungs of the animals on day 5 and evaluated using colony PCR
M.J. Memoli et al. / Virology 428 (2012) 21–2928techniques to determine the prevalence of mutations at position
222 of the HA1 domain in quasispecies. Thirty colonies from each
were chosen for analysis. Comparisons were made to the original
isolates used for inoculation. Custom overlapping primers were
used to sequence the full HA gene for each clone (primers
available upon request).
Histopathologic analysis
Tissue samples from every ferret including nasal cavity, larynx,
trachea and lung were ﬁxed in 10% neutral buffered formalin, and
processed using standard protocols. Hematoxylin-and-eosin
(H&E) stains were performed on all tissues using standard
methods. Tissue Gram stains were performed on selected tissues.
Immunohistochemistry for inﬂuenza A ﬂu antigen distribution,
using goat polyclonal anti-H1N1 (ab20841, Abcam, Cambridge,
MA), was completed on a subset of the tissues that represented all
acute time point ferrets’ lungs and a representative piece of nasal
cavity, larynx and trachea for each virus from both inoculated and
transmission animals using standard methods.
Two pathologists reviewed all slides. Lung pathology was
assessed taking into account the pathology severity as well as
its distribution and degree of lung involvement in the examined
tissues.
Phylogenetic analysis
Codon analysis of viruses isolated from nasal turbinates and
lungs of ferrets at day 5 was compared to the codon usage of site
222 of available HA sequences of A(H1N1)pdm09. Phylogenetic
analysis was performed on 1500 HA (1701 nt) and 680 NA
(1410 nt) sequences downloaded from the Inﬂuenza Virus
Resource http://www.ncbi.nlm.nih.gov/genomes/FLU/FLU.html and/or
GenBank. The best-ﬁt GTRþ IþG4 model of nucleotide substitu-
tion was determined using ModelTest 3.7 (Posada and Crandall,
1998), and resulting parameter estimates were imported into
PAUP* (Swofford, 2003) to create maximum likelihood (ML) trees
through TBR branch-swapping (parameter values available upon
request). Amino acid and codon differences at the variable amino
acid site 222 in the HA protein were recorded using MacClade
(Maddison and Maddison, 1989).Acknowledgments
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